Abstract
E16038 Background: Prostate-specific membrane antigen (PSMA) shows increased expression on most prostate cancers (PCa). Aim of this retrospective analysis of consecutive pts was to evaluate the accuracy of Glu-NH-CO-NH-Lys-(Ahx)-[(68)Ga(HBED-CC)] (68Ga-HBED-PSMA) a recently developed ligand of PSMA, for the preoperative staging of lymph node (LN) involvement in primary PCa. Methods: 92 consecutive pts with intermediate to high-risk PCa received 68Ga-HBED-PSMA-PET/MR and were included in this analysis. One nuclear medicine physician and one radiologist reviewed PET/MRI imaging in consensus. Pelvine LN dissection was performed according to a predefined template. LN involvement was evaluated according to a 5-point scale on a patient- and field-based manner and correlated to postoperative histological analysis. Results: Due to lacking PSMA expression of the primary PCa 4 pts were excluded from further analysis. In total, 20 pts showed metastatic LN. 68Ga-HBED-PSMA-PET/MR detected 15 out of 20 pts with histolo...